European Medical Solutions (EBR:ALEMS)
Belgium
· Delayed Price · Currency is EUR 5.50
+0.30 (5.77%)
Dec 5, 2025, 3:48 PM CET
EBR:ALEMS Revenue
European Medical Solutions had revenue of 24.76M EUR in the half year ending June 30, 2025, with 13.60% growth. This brings the company's revenue in the last twelve months to 49.47M, up 12.63% year-over-year. In the year 2024, European Medical Solutions had annual revenue of 47.91M with 12.67% growth.
Revenue (ttm)
49.47M
Revenue Growth
+12.63%
P/S Ratio
0.47
Revenue / Employee
402.23K
Employees
122
Market Cap
23.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47.91M | 5.39M | 12.67% |
| Dec 31, 2023 | 42.53M | 5.47M | 14.76% |
| Dec 31, 2022 | 37.06M | -963.00K | -2.53% |
| Dec 31, 2021 | 38.02M | 37.66M | 10,491.90% |
| Dec 31, 2020 | 358.94K | -705.90K | -66.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 3.14B |
| UCB SA | 6.85B |
| Financière de Tubize | 13.26K |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| Onward Medical | 2.72M |
| Hyloris Pharmaceuticals | 8.46M |
| Nyxoah | 5.64M |